Patient information on prescribed drugs

BMJ

Volumn 343, Issue 7814, 2011, Pages

  Shaw, Joanne ^a  

^a Datapharm Communications Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; DRUG INFORMATION; DRUG LEGISLATION; EDITORIAL; EUROPE; HEALTH EDUCATION; HUMAN; MEDICAL SOCIETY; PATIENT INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; PATIENT EDUCATION;

PRESCRIPTION DRUG;

HUMANS; PATIENT EDUCATION AS TOPIC; PRESCRIPTION DRUGS;

EID: 79960084375     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d1924     Document Type: Editorial

References (6)

1. European Parliament. Legislative resolution of 24 November 2010 on the proposal for a directive of the European Parliament and of the council amending, as regards information to the general public on medicinal products subject to medical prescription, Directive 2001/83/EC on the Community code relating to medicinal products for human use (COM(2008)0663 - C6-0516/2008 - 2008/0256(COD)). 2010. www.europarl.europa.eu/ sides/getDoc.do?type= TA&reference=P7-TA-2010-0429&format=XML&language=EN.
2. FASS - Swedish Medicines Information Engine. www.lif.se/cs/default.asp? id=11986.
3. eMC Medical Guidelines. www.medicines.org.uk/guides.
4. Montori VM, Shah ND. What have we learnt from the rosiglitazone saga? BMJ 2011;342:d1354.
5. Benkimoun P. France plans overhaul of drug regulation. BMJ 2011;342:d1829.
6. BUPA. Health and wellbeing. www.bupa.com/mediacentre/healthpulse/ healthandwellbeing.